您的位置:首页 > 产品中心 > HCV-NS4A/NS3-1b Protease, Histag, strain HC-J4 from hepatitis C virus
HCV-NS4A/NS3-1b Protease, Histag, strain HC-J4 from hepatitis C virus
产品编号: | 4119126 |
规格: | recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
包装规格: | 10 μG |
产品类别: | 进口试剂 |
品牌: | Sigma-Aldrich |
优惠价: | 立即咨询 |
产品别名
HCV-NS4A/NS3-1b Protease, Histag, strain HC-J4 from hepatitis C virus
Hepatitis C virus NS3 protease
NS4ANS3 complex
NS3
pfam02907
基本信息
NACRES | NA.26 |
Biochem/physiol Actions【生化/生理作用】 | Persistent infection with hepatitis C virus (HCV) is a common cause of chronic liver disease, including chronic hepatitis, cirrhosis, and hepatocellular carcinoma. HCV is an enveloped, single-stranded RNA virus with a 9.6-kb positive-polarity genome, which encodes a polyprotein precursor of about 3,000 amino acids. The HCV polyprotein is proteolytically processed by cellular and HCV proteases into at least 10 distinct products. NS3 serine protease and helicase as well as NS5B RNA-dependent RNA polymerase are believed to be components of a replication complex responsible for viral RNA replication and have been shown to be essential for the HCV replication in chimpanzees. These HCV enzymes have been the major targets for the development of HCV-specific therapeutics during the past decade. The HCV NS3/4A protease is responsible for cleavage at four sites within the HCV polyprotein to generate the N termini of the NS4A, NS4B, NS5A, and NS5B proteins. It has been shown that the central region (amino acids 21-30) of the 54-residue NS4A protein is essential and sufficient for the enhancement of proteolytic activity of the NS3 serine protease. In recent phase I trials, a 2-3-log reduction of HCV viral load was observed after a 2-day treatment with a serine protease inhibitor, which provided the first proof-of-concept evidence that HCV NS3/4A protease inhibitors could be a new therapeutic option for hepatitis C patients. |
Physical form【外形】 | Clear and colorless frozen liquid solution |
Preparation Note【制备说明】 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. While working, please keep sample on ice. |
产品性质
biological source【生物来源】 | hepatitis C virus |
recombinant【重组】 | expressed in E. coli |
Assay【测定】 | ≥80% (SDS-PAGE) |
form【形式】 | frozen liquid |
mol wt【分子量】 | ~22.7 kDa |
packaging【包装】 | pkg of 10 μg |
concentration【浓度】 | 500 μg/mL |
color【颜色】 | colorless to clear |
NCBI accession no.【NCBI登记号】 | X61596 |
shipped in【运输】 | dry ice |
storage temp.【储存温度】 | −70℃ |
Gene Information | hepatitis C virus ... HCVgp1(951475) |
安全信息
Storage Class Code【储存分类代码】 | 10 - Combustible liquids |
WGK | WGK 1 |